人类免疫缺陷病毒感染者和实体器官移植受者中的间变性大细胞淋巴瘤
基于美国癌症登记与HIV登记(1996-2016)及全国移植登记(1992-2017)的链接数据,研究者在HIV感染者(86例)和移植受者(35例)中识别出121例间变性大细胞淋巴瘤(ALCL),其发病风险显著高于一般人群(SIR分别为5.43和5.96);HIV感染者中ALCL发生与CD4计数强相关,移植受者风险在移植后第1年及10年以上最高;基于有限病理报告,ALCL可能与EBV感染无关。
要点
- HIV感染者和移植受者ALCL风险显著升高,SIR分别为5.43和5.96。
- HIV感染者CD4≥500 vs <200 cells/μl的aIRR为0.15,趋势P<0.001。
- 移植受者ALCL风险在移植后第1年(aIRR 6.82)和10年以上(5.99)最高。
核心结论
- 在这些免疫抑制人群中ALCL风险强烈升高,但基于有限报告可能与EBV感染无关。
研究设计与样本
- 使用美国癌症登记与HIV登记(1996-2016)及全国移植登记(1992-2017)链接数据,计算标准化发病比(SIR),并用泊松回归评估风险因素。
- 在HIV人群(n=86)和移植人群(n=35)中共识别121例新发ALCL病例。
- 对45例病理报告进行复核,其中86.7%确认为ALCL。
主要发现
- 与一般人群相比,HIV感染者ALCL风险升高(SIR 5.43;95%CI 4.27-6.81),移植受者风险亦升高(SIR 5.96;95%CI 4.03-8.49)。
- HIV感染者中ALCL发生率与CD4计数强相关(≥500 vs <200 cells/μl的aIRR 0.15;趋势P<0.001)。
- 移植受者中风险在移植后第1年最高(aIRR 6.82),10年以上亦高(aIRR 5.99)。
- EBV检测在1/8(12.5%)病例中呈阳性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human immunodeficiency virus (HIV)-infected people and solid organ transplant recipients have elevated risk of anaplastic large cell lymphoma (ALCL). Little is known regarding ALCL risk factors in immunosuppressed populations. We used data from US cancer registries linked to HIV registries (1996-2016) and to the national transplant registry (1992-2017). ALCL risk in HIV-infected people and transplant recipients relative to the general population was calculated as a standardized incidence ratio (SIR). ALCL risk factors were evaluated using Poisson regression. We identified 121 incident ALCL cases in the HIV (n = 86) and transplant (n = 35) populations. We reviewed pathology reports for 45 cases and most (86·7%) were confirmed as ALCL. Epstein-Barr virus tested positive in 1/8 (12·5%) cases. Compared to the general population, ALCL risk was strongly elevated among HIV-infected people [SIR 5·43; 95% confidence interval (CI) 4·27-6·81] and transplant recipients (5·96; 4·03-8·49). Among HIV-infected people, ALCL incidence was strongly related to CD4 count [adjusted incidence rate ratio (aIRR) 0·15 for ≥500 vs. <200 cells/μl; P trend < 0·001]. Among transplant recipients, risk was highest within the first year (aIRR 6·82) and 10+ years post-transplant (5·99). In conclusion, ALCL risk is strongly increased in these immunosuppressed populations but may be unrelated to EBV infection based on limited reports.
引用
- Mahale P, Weisenburger DD, Kahn AR, et al. Anaplastic large cell lymphoma in human immunodeficiency virus-infected people and solid organ transplant recipients. Br J Haematol. 2020. PMID: 32510592. doi:10.1111/bjh.16778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。